Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Townsend Richard Nolan sold 3,342 Lexeo Therapeutics, Inc. shares (Form 4)

Traded May 18, 2026 · Filed May 20, 2026

On May 18, 2026, Townsend Richard Nolan (Director, Chief Executive Officer) sold 3,342 Lexeo Therapeutics, Inc. shares at US$5.06 for US$16,911, leaving 336,764 shares. Filed May 20, 2026 (Form 4).

Sold
3,342 shares
Price
US$5.06
Value
US$16,911
Holding after
336,764 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockSale3,342US$5.06336,764Direct

Source

View original at SEC

Related